Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 2.2 Certificate of Merger As Filed with the Delaware Secretary of State Effective October 28, 2022
- 3.1 Amended and Restated Certificate of Incorporation of Coeptis Therapeutics Holdings, Inc.
- 3.3 Amended and Restated Bylaws of Coeptis Therapeutics Holdings, Inc.
- 4.1 2022 Equity Incentive Plan
- 21.1 Subsidiaries of Coeptis Therapeutics Holdings, Inc.
- 23.1 Consent of Independent Registered Public Accounting Firm
- 99.1 Audited Financial Statements of Coeptis Therapeutics, Inc.
- 99.2 Unaudited Pro Forma Condensed Combined Financial Statements for the Year Ended December 31, 2021 and As of and for the Six Months Ended June 30, 2022
- 99.3 Coeptis Therapeutics Holdings Inc. Presentation
- 99.4 Coeptis Therapeutics Inc. Press Release Dated October 31, 2022
- 99.5 Coeptis Therapeutics Holdings Inc. Press Release Dated November 2, 2022
- Download Excel data file
- View Excel data file
COEPW similar filings
- 17 May 23 Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
- 31 Jan 23 Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development Program
- 29 Dec 22 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 3 Nov 22 Index to Financial Statements
- 26 Oct 22 Submission of Matters to a Vote of Security Holders
- 6 Jul 22 Regulation FD Disclosure
- 20 May 22 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 10, 2022 with respect to the financial statements of Coeptis Therapeutics, Inc. contained in the Form 8-K of Bull Horn Holdings Corp. We consent to the use of our aforementioned report in the Form 8-K, and to the use of our name as it appears under the caption “Experts.”
/s/ TURNER, STONE & COMPANY, LLP
Dallas, Texas
November 3, 2022